We are live on ! Find out more

Small Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ARDX icon
76
Ardelyx
ARDX
$1.25B
$1.25B $5.08 0.4%
AHG
77
Akso Health Group
AHG
$1.25B
$1.25B – –
OPK icon
78
Opko Health
OPK
$1.25B
$1.25B $1.65 33.1%
ORIC icon
79
Oric Pharmaceuticals
ORIC
$1.23B
$1.23B $11.91 0.92%
AVLN
80
Avalyn Pharma
AVLN
$1.23B
$1.23B $27.79 0.62%
CERT icon
81
Certara
CERT
$1.23B
$1.23B $7.91 2.06%
TNDM icon
82
Tandem Diabetes Care
TNDM
$1.22B
$1.22B $17.76 3.44%
OMDA
83
Omada Health Inc
OMDA
$1.21B
$1.21B $20.43 0.73%
IRMD icon
84
iRadimed
IRMD
$1.21B
$1.21B $94.83 0.26%
NVAX icon
85
Novavax
NVAX
$1.21B
$1.21B $7.37 1.6%
MNKD icon
86
MannKind Corp
MNKD
$1.21B
$1.21B $3.91 1.01%
ABSI icon
87
Absci
ABSI
$1.21B
$1.21B $7.13 5.69%
USPH icon
88
US Physical Therapy
USPH
$1.2B
$1.2B $79 3.08%
JBIO
89
Jade Biosciences
JBIO
$1.2B
$1.2B $19.70 1.25%
IMTX icon
90
Immatics
IMTX
$1.19B
$1.19B $8.73 1.16%
INBX icon
91
Inhibrx
INBX
$1.17B
$1.17B $79.68 3.36%
COLL icon
92
Collegium Pharmaceutical
COLL
$1.16B
$1.16B $35.90 1.07%
FRNM
93
Freenome, Inc. Common stock
FRNM
$1.14B
$1.14B $10.77 5.36%
SDGR icon
94
Schrodinger
SDGR
$1.14B
$1.14B $15.29 0.07%
QDEL icon
95
QuidelOrtho
QDEL
$1.14B
$1.14B $16.67 0.95%
WVE icon
96
Wave Life Sciences
WVE
$1.13B
$1.13B $5.89 0.51%
STAA icon
97
STAAR Surgical
STAA
$1.13B
$1.13B $22.66 1.26%
CRVS icon
98
Corvus Pharmaceuticals
CRVS
$1.12B
$1.12B $13.31 3.02%
IVA
99
Inventiva
IVA
$1.1B
$1.1B $4.64 0.87%
MGTX icon
100
MeiraGTx Holdings
MGTX
$1.09B
$1.09B $11.82 3.9%
2 3
4
5 6

Small Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 301 small cap Healthcare stocks — companies in the Healthcare sector with a market cap between $250M and $2B — worth a combined $267B.

The largest by market cap are UFP Technologies (UFPT) at $2B, UroGen Pharma (URGN) at $1.99B and SELLAS Life Sciences (SLS) at $1.98B.

Among institutional investors, Aktis Oncology (AKTS) drew the most net new fund positions in Q1 2026: 69 funds opened new positions.

  • Combined market cap: $267B across 301 stocks.
  • Small Cap: market cap between $250M and $2B.
  • Largest constituent: UFP Technologies (UFPT), $2B market cap.
  • Most net new fund positions in Q1 2026: Aktis Oncology (AKTS), +69 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.